v3.20.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 70,203 $ 74,317
Short-term investments 144,428 184,792
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 14,392 13,689
Total current assets 229,217 272,992
Property and equipment, net 54,442 54,176
Operating lease assets 13,691 14,007
Restricted cash - long-term 1,200 1,200
Other assets 997 567
Total assets 299,547 342,942
Current liabilities:    
Accounts payable 8,079 7,963
Accrued compensation 9,676 14,706
Accrued research and development expenses 7,827 8,341
Other current liabilities 5,938 5,733
Total current liabilities 31,520 36,743
Operating lease liabilities - long-term 13,809 14,136
Other long-term liabilities 1,396 1,282
Total liabilities 46,725 52,161
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of March 31, 2020 and December 31, 2019; 58,940 and 56,806 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 6 6
Additional paid-in capital 1,144,082 1,108,516
Accumulated other comprehensive income 204 220
Accumulated deficit (891,470) (817,961)
Total stockholders’ equity 252,822 290,781
Total liabilities and stockholders’ equity $ 299,547 $ 342,942

Source